Precision pharmacogenomics is more than static genotypes. Today we’re excited to announce that PGxAI’s base models now include built-in phenoconversion: our engine automatically adjusts genotype-derived phenotypes in real time by accounting for co-medications, inhibitors/inducers, and other clinical factors.
The result is a dynamic, context-aware sensitivity score that tracks each individual’s evolving drug-response profile rather than a one-off prediction. Phenoconversion runs natively in our web terminal and scales to high-throughput workloads through the same REST API you already use for bulk uploads and report retrieval.
We see this as a pivotal step toward eliminating adverse reactions caused by overlooked drug-drug interactions and metabolic shifts. Whether you need a single compound check or automated, panel-wide decision support, phenoconversion is now just an upload—or an API call—away.
Ready to integrate or learn more? Reach out via our contact form and let’s accelerate safer, smarter therapeutics together.